SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Sable Offshore Corp. (NYSE: SOC) is now at the center of a securities class-action lawsuit, alleging that the company misled investors to inflate its stock price just before a major secondary offering. The drama unfolded around the company's long-delayed efforts to restart operations at its San Ynez Unit (SYU) assets, which have been dormant since a pipeline shutdown in 2015.

image for news Sable Offshore Corp. (SOC) Hit With Lawsuit Over Alleged Misleading Statements on California Oil Restart – Hagens Berman

SWK Holdings Corporation (SWKH) Q2 2025 Earnings Call Transcript — Neutral

SWKH   Seeking Alpha — August 15, 2025

SWK Holdings Corporation (NASDAQ:SWKH ) Q2 2025 Earnings Conference Call August 15, 2025 10:00 AM ET Company Participants Adam Christopher Rice - CFO and Principal Financial & Accounting Officer Jody. D Staggs - CEO & President Conference Call Participants Scott Jensen - Unidentified Company Susan Xu - Unidentified Company Operator Greetings.

image for news SWK Holdings Corporation (SWKH) Q2 2025 Earnings Call Transcript

So-Young International Inc. (SY) Q2 2025 Earnings Call Transcript — Neutral

SY   Seeking Alpha — August 15, 2025

So-Young International Inc. (NASDAQ:SY ) Q2 2025 Earnings Conference Call August 15, 2025 7:30 AM ET Company Participants Hui Zhao - CFO & Director Mona Qiao - Investor Relation Officer Xing Jin - Co-Founder, CEO & Chairman Conference Call Participants Fuk Lung Cheung - Citigroup Inc., Research Division Kewei Chen - Haitong International Research Limited Yiteng Li - Haitong International Research Limited Operator Ladies and gentlemen, thank you for standing by for So-Young's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded.

image for news So-Young International Inc. (SY) Q2 2025 Earnings Call Transcript

General Dynamics Wins $323M Deal to Support Submarine Program — Positive

GD   Zacks Investment Research — August 15, 2025

General Dynamics secures a $322.6M Navy contract for Electric Boat to provide critical submarine engineering and support services.

image for news General Dynamics Wins $323M Deal to Support Submarine Program

SBH's E-Commerce Sales Hit 11% of Net Sales: Can it Keep Rising? — Neutral

SBH   Zacks Investment Research — August 15, 2025

Sally Beauty's e-commerce now drives 10.6% of net sales, powered by marketplaces, innovation and targeted promotions.

image for news SBH's E-Commerce Sales Hit 11% of Net Sales: Can it Keep Rising?

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al.

image for news Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug - Hagens Berman

OMAH: I'd Rather Just Own Berkshire Hathaway — Neutral

BRK-A  BRK-B  OMAH   Seeking Alpha — August 15, 2025

OMAH is an ETF built on Berkshire Hathaway's securities portfolio. It earns a high 15% distribution yield selling covered calls on the portfolio. Berkshire's investment approach and long-term value focus argue that its stock portfolio should rise long term. So, OMAH's covered call writing should hold back long term gains.

image for news OMAH: I'd Rather Just Own Berkshire Hathaway

Applied Materials shares slide on weak Q4 guidance — Negative

AMAT   Proactive Investors — August 15, 2025

Applied Materials Inc (NASDAQ:AMAT, ETR:AP2) shares fell 13.2% on Friday after the semiconductor equipment maker issued weaker-than-expected guidance for the fourth quarter. The company expects revenue around $6.7 billion and EPS near $2.11, both below analysts' forecasts of $7.32 billion and $2.38.

image for news Applied Materials shares slide on weak Q4 guidance

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- On July 24, 2025, the European Medicines Agency (“EMA”) recommended the refusal of the marketing authorization for ELEVIDYS, Sarepta's medication intended for the treatment of Duchenne muscular dystrophy. This news prompted another significant decline in the price of Sarepta (NASDAQ: SRPT) shares.

image for news Sarepta Therapeutics (SRPT) Declines Again On EMA Recommendation to Refuse ELEVIDYS Marketing Authorization, Securities Class Action Pending – Hagens Berman

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 financial results.

image for news Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman

NICE Grows Through Expanding Portfolio and Strong Partnerships — Positive

NICE   Zacks Investment Research — August 15, 2025

NICE rides cloud growth, AI-driven CXone adoption, and deepened Salesforce ties to boost revenue and expand customer reach.

image for news NICE Grows Through Expanding Portfolio and Strong Partnerships

Petrobras Q2 Earnings Miss on Oil Price Drop, Production Grows — Negative

PBR   Zacks Investment Research — August 15, 2025

PBR posts lower Q2 earnings on weaker oil prices despite higher production, while boosting dividends and investments.

image for news Petrobras Q2 Earnings Miss on Oil Price Drop, Production Grows

Cardinal Health to Acquire Solaris Health for Urology Expansion — Positive

CAH   Zacks Investment Research — August 15, 2025

CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.

image for news Cardinal Health to Acquire Solaris Health for Urology Expansion

Can Eylea HD and Dupixent Profits Revive Regeneron Stock? — Positive

REGN   Zacks Investment Research — August 15, 2025

REGN banks on Dupixent and Eylea HD gains to offset Eylea's decline while oncology wins strengthen its diversified pipeline.

image for news Can Eylea HD and Dupixent Profits Revive Regeneron Stock?

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea — Positive

NYXH   Zacks Investment Research — August 15, 2025

NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.

image for news Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Marex Group plc (NASDAQ: MRX) saw the price of their shares significantly decline in the wake of a critical short report accusing the company of engaging in an improper multi-year accounting scheme.

image for news Marex Group (MRX) Faces Investor Scrutiny Amid Short Seller Accusations – Hagens Berman

Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy — Neutral

AMAT   MarketBeat — August 15, 2025

Applied Materials NASDAQ: AMAT gave its market a reason to sell with its Q3 results. However, the 15% pre-market decline is a knee-jerk reaction to news that opens up a solid buying opportunity.

image for news Applied Materials' Knee-Jerk Sell-Off Is Your Signal to Buy

Applied Materials topped Wall Street's third-quarter earnings estimates but issued light guidance due to macroeconomic pressures. CEO Gary Dickerson said the current macroeconomic backdrop and trade issues have fueled "increasing uncertainty and lower visibility," primarily within its China business

image for news Applied Materials sinks 13% on weak guidance due to China demand

Will AI-Driven Fiber Boom Boost MasTec's Communications Business? — Positive

MTZ   Zacks Investment Research — August 15, 2025

MTZ posts record Q2 results as AI-fueled fiber demand propels 42% growth in its Communications segment and a $5B backlog.

image for news Will AI-Driven Fiber Boom Boost MasTec's Communications Business?

Sandisk Stock Drops as Profit Estimates Come Up Short on Fab Startup Costs — Negative

SNDK   Investopedia — August 15, 2025

Sandisk (SNDK) shares slumped Friday, a day after the maker of computer flash drives gave lower-than-expected profit guidance as startup costs increase.

image for news Sandisk Stock Drops as Profit Estimates Come Up Short on Fab Startup Costs